|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dockets Entered On June 19, 2003
TABLE OF CONTENTS (Linked) |
|
|
|
|
|
Docket #
|
Title |
|
|
|
|
|
|
2003P-0283
|
ANDA Suitability for Glimepiride
Tablets, 8 mg |
|
|
|
|
|
|
2003P-0284 |
Lexapro (escitalopram oxalate)
tablets 5mg (NDA 21-323, Product 001),mfged by Forest Laboratories
have been voluntarily withdrawn or withheld from sale for safety
or efficacy reasons |
|
|
| CONTENTS |
|
|
1993M-0212 |
|
PMA of Gianturco-Roubin Flex-Stent |
|
|
|
|
|
|
|
AAV 1
|
|
Approval of Application |
|
Vol #: |
|
1 |
|
|
|
|
|
2000N-1396 |
|
Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
|
|
|
EMC 11565 |
|
Tracy Jackson |
|
Vol #: |
|
349 |
|
|
|
|
|
2000N-1571 |
|
Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
|
|
|
|
|
EXB 20 |
|
Center for Veterinary Medicine |
|
Vol #: |
|
378 |
|
|
|
|
|
2003P-0283 |
|
ANDA Suitability for Glimepiride
Tablets, 8 mg |
|
|
|
|
|
ACK 1
|
|
HFA-305 to Lanchan Consultant Services, Inc
|
|
Vol #: |
|
1 |
|
|
|
|
|
CP 1
|
|
Lachman Consultant Services, Inc. |
|
Vol #: |
|
1 |
|
|
|
|
|
2003P-0284 |
|
Lexapro (escitalopram oxalate)
tablets 5mg (NDA 21-323, Product 001),mfged by Forest Laboratories
have been voluntarily withdrawn or withheld from sale for safety
or efficacy reasons |
|
|
|
ACK 1
|
|
HFA-305 to Lachman Consultant Services, Inc.
|
|
Vol #: |
|
1 |
|
|
|
|
|
CP 1
|
|
Lachman Consultant Services, Inc. |
|
Vol #: |
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
